- Hjemme /
- Litteraturhenvisninger
Litteraturhenvisninger
Vild virus er en populærvidenskabelig bog, der både bygger på videnskabelige artikler, populærvidenskabelige og fagbøger, aktindsigter og avisartikler fra danske og internationale medier. Nedenfor kan du finde den litteratur, der ligger til grund for hvert kapitel. Den videnskabelige litteratur kan hentes på søgemaskinen PubMed.
Alle citater fra regeringens pressemøder er hentet fra Statsministeriets pressemødearkiv: https://www.stm.dk/presse/pressemoedearkiv/
Data for smittetal, vaccinetilslutning, offentlige risikovurderinger mv., er hentet hos Statens Serum Institut: https://covid19.ssi.dk/ og hos Sundhedsstyrelsen: https://www.sst.dk/da/.
Desuden er interne risikovurderinger fra Statens Serum Institut oversendt til Sundhedsstyrelsen januar-marts 2020 anvendt. Derudover har jeg flittigt har gjort brug af mine egne og journalist Anders Legarth Schmidts journalistiske artikler fra vores dækning af pandemien i Politiken:
Lars
Se artiklerAnders
Se artiklerKapitel 2 - Den nye tids pest
- Aids-epidemien i Danmark, ca. 1981-1996
- HIV - Human immundefekt virus
- Pneumocystis pneumoni (PCP)
- Identification of Pneumocystis carinii chromosomes and mapping of five genes
For yderligere videnskabelig læsning om hiv-aids :
- An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction
- Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency
- Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)
- Ending the HIV-AIDS Pandemic--Follow the Science
- Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
- Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
- Four Decades of HIV/AIDS - Much Accomplished, Much to Do
Kapitel 3 - Fuglene sætter en skræk i livet på fagfolk
For yderligere videnskabelig læsning om fugleinfluenza H5N1:
Kapitel 4 – SARS – en ny coronavirus skaber frygt
Verdenshistoriens største epidemier, Jacob Eberhardt, Fadl’s Forlsag
For yderligere videnskabelig læsning om SARS:
- Identification of severe acute respiratory syndrome in Canada
- A cluster of cases of severe acute respiratory syndrome in Hong Kong
- Identification of a novel coronavirus in patients with severe acute respiratory syndrome
- A novel coronavirus associated with severe acute respiratory syndrome
- SARS-associated coronavirus
- SARS: responding to an unknown virus
- The relationship of severe acute respiratory syndrome coronavirus with avian and other coronaviruses
Kapitel 5 - Svinealarm bliver en fuser
- From Édgar, 5, Coughs Heard Round the World
- Study puts global 2009 pandemic H1N1 infection rate at 24%
- INFLUENZA A H1N1 AF NY SUBTYPE (SVINEINFLUENZA)
- Den spanske syge 1918-1920
- Der er langt fra svineinfluenza til spansk syge
- INFLUENZA-PANDEMIFASER OG PANDEMIPLANLÆGNING
- Uge 23 - 2010 Influenzasæsonen 2009-2010
- Influenza A (H1N1)
- U.S. Says Older People Appear Safer From New Flu Strain
- First Global Estimates of 2009 H1N1 Pandemic Mortality Released by CDC-Led Collaboration
- Sundhedsstyrelsen: 3.000 danskere vil dø af Influenza A
- Study supports overall effectiveness of 2009 H1N1 vaccine
For yderligere videnskabelig læsning om pandemien med svineinfluenza A H1N1:
- Bacterial pathogens and death during the 1918 influenza pandemic
- Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1)
- Severe respiratory disease concurrent with the circulation of H1N1 influenza
- Information technology and global surveillance of cases of 2009 H1N1 influenza
- The public's response to the 2009 H1N1 influenza pandemic
- Pandemic preparedness and response--lessons from the H1N1 influenza of 2009
Kapitel 6 – Ebola – Når mange på tillid spreder smitte
- Integrating Clinical Research into Epidemic Response
- Rigorous Clinical Trial Design in Public Health Emergencies Is Essential
- Ebola
- 2014 Ebola virus outbreak: Facts, symptoms, and how to help
- 2018 Annual review of diseases prioritized under the Research and Development Blueprint
For yderligere videnskabelig læsning om ebola:
- After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics
- Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- The Ongoing Ebola Epidemic in the Democratic Republic of Congo, 2018-2019
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Kapitel 7 - Mystisk lungebetændelse i Wuhan
- Animal sales from Wuhan wet markets immediately prior to the COVID-19 pandemic
- The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic
- Coronavirus: WHO calls for halt to sale of live wild mammals in food markets to limit disease risk
- Wuhan Wet Market Worker Is Now the 1st Known Case of COVID-19, According to New Study
- Mission summary: WHO Field Visit to Wuhan, China 20-21 January 2020
- COVID-19 almost certainly did not come from a lab leak. Here’s how we know
- Håndteringen af covid-19 i foråret 2020
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
For yderligere videnskabelig læsning om SARS-CoV-2 og Wuhan:
- The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic
- The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
- A new coronavirus associated with human respiratory disease in China
- Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
Kapitel 8 - Skibet er ladet med smitte
- 27 Days in Tokyo Bay: What Happened on the Diamond Princess
- Natural History of Asymptomatic SARS-CoV-2 Infection
- Influenza
- Sundhedsstyrelsen ændrer risikovurdering og udsender nye retningslinjer for håndtering af COVID-19
- Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21
For yderligere videnskabelig læsning om Diamond Princess, R0 og dødelighed:
- Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020
- A review of COVID-19 transmission dynamics and clinical outcomes on cruise ships worldwide, January to October 2020
- Taking account of asymptomatic infections: A modeling study of the COVID-19 outbreak on the Diamond Princess cruise ship
Kapitel 9 - Point of no return
- Italy: First measures
- Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
- Visualised: how Ebola compares to other infectious diseases
For yderligere videnskabelig læsning om udbruddet i Italien og Europa:
Kapitel 10 – Så skete det – Danmark er ramt
- Syv døgn med Danmarks første corona-patient: »Det er sgu godt, jeg ikke er typen, der krammer alle kolleger«
- Håndteringen af covid-19 i foråret 2020
- COVID-19: too little, too late?
For yderligere videnskabelig læsning om udbruddet i Danmark:
Kapitel 11 – Brace for impact – Den første bølge
- Sundhedsstyrelsen: Selv i skrækscenariet vil Danmark have respiratorer nok til at behandle kritisk syge coronapatienter
- "Entschuldigung, aber ich muss weinen"
- Bergamo vil helst glemme corona, men Sara Invernizzi og Diego Federici er stadig i chok
For yderligere videnskabelig læsning om første smittebølge i Europa og Danmark:
Kapitel 12 – Test. Test, test
- Vi massetester for milliarder - nu vil politisk flertal have undersøgt, om det overhovedet virker
- Mærsk-oprettet "luftbro" i kraft: Kæmpe fragtfly har afleveret tonsvis af værnemidler i København
For yderligere videnskabelig læsning om test:
- Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19
- Risk of COVID-19 in health-care workers in Denmark: an observational cohort study
- Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers
Kapitel 13 – Louises sene sygdom
- Systematisk gennemgang af litteratur om senfølger efter Covid-19
- A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark
For yderligere videnskabelig læsning om senfølger:
- Long-COVID treatments: why the world is still waiting
- Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study
- Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study
- Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
- Post-acute COVID-19 syndrome
- Long COVID in a prospective cohort of home-isolated patients
Kapitel 14 – Det medicinske gennembrud
- Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy
- Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy
For yderligere videnskabelig læsning om remdesivir og medicin til alle faser af covid:
- Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy
- Remdesivir for the Treatment of Covid-19 - Final Report
- Remdesivir against COVID-19 and Other Viral Diseases
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- Dexamethasone in Hospitalized Patients with Covid-19
- Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
- A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
Kapitel 15 – Angreb fra luften
- Festen, hvor de fleste blev smittet: »Vi var så lykkelige og svævede på en lyserød sky, men så ringede telefonen«
- Covid-19: Forebyggelse af smittespredning
- Size- and Time-Dependent Particle Removal Efficiency of Face Masks and Improvised Respiratory Protection Equipment Used during the COVID-19 Pandemic
For yderligere videnskabelig læsning om aerosolsmitte fra SARS-CoV-2:
- Long distance airborne transmission of SARS-CoV-2: rapid systematic review
- Possible aerosol transmission of COVID-19 associated with an outbreak in an apartment in Seoul, South Korea, 2020
- High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice - Skagit County, Washington, March 2020
- Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control
- SARS-CoV-2 air sampling: A systematic review on the methodologies for detection and infectivity
- Coronavirus disease (COVID-19): How is it transmitted?
- The role of SARS-CoV-2 aerosol transmission during the COVID-19 pandemic
Kapitel 16 – Mink stjæler fokus, da smitten vender tilbage
- Bliver anden bølge af coronaepidemien bare et skvulp?
- Statsministeren ser intet behov for stor nedlukning til efteråret
- Historisk stor erstatning: 18.770.000.000 kroner på vej til minkbranchen
- Bred aftale om ny epidemilov
- Human sundhed risikovurdering med fortsat minkproduktionen
- Mutationer i minkvirus
- Preliminary rapport on SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data. SARS-CoV-2 spike mutations arising in Danish mink and their spread to humans
- Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020
- In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms
For yderligere videnskabelig læsning om mink, 2. smittebølge mv:
- Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
- The basis of mink susceptibility to SARS-CoV-2 infection
- SARS-CoV-2 Outbreak on a Spanish Mink Farm: Epidemiological, Molecular, and Pathological Studies
- The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization
- SARS-CoV-2 spike D614G change enhances replication and transmission
- Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020
Kapitel 17 – Kanyler fyldt med håb
- Covid-19-infektioner efter vaccination og vaccineeffektivitet - Status uge 41
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- A human monoclonal antibody blocking SARS-CoV-2 infection
- Iskold og dyrebar: Her er corona-vaccinens vej fra belgisk laboratorium til danske overarme
- Et hidtil uset forløb: Et stik naglede et afgørende søm i AstraZenecas kiste
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
For yderligere videnskabelig læsning om vacciner mod Covid-19, Vitt, bivirkninger efter covid-vaccination samt Enforce:
- Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Kapitel 18 – Kapløb med mutationerne
- Genomic epidemiology of SARS-CoV-2 with subsampling focused globally over the past 6 months
- Dukke af Mette Frederiksen med truende besked brændt af under demonstration
- Nye smitsomme mutationer bekymrer: »Vi er slet ikke færdige med det her«
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- Variants concern
- Et hidtil uset forløb: Et stik naglede et afgørende søm i AstraZenecas kiste
- VURDERING VEDRØRENDE GENÅBNING FRA FAGLIG REFERENCEGRUPPE TIL COVID-19 NATIONALT VARSLINGSSYSTEM
- Prognoser for smittetal med fokus på udviklingen i cluster B.1.1.7
For yderligere videnskabelig læsning om de anførte mutationer og varianter:
Kapitel 19 – Det svære efterår
- Ekspertgruppen om en langsigtet strategi for et genåbnet Danmark offentliggør sin rapport
- ‘The war has changed’: Internal CDC document urges new messaging, warns delta infections likely more severe
- Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study
- Det er slut: Hospitaler dropper særlig indsats mod corona
- Udfordring af sygehuskapaciteten i efterår og vinter 2021/2022
- Retningslinje for håndtering af vaccination mod covid-19 i det generelle vaccinationsprogram
For yderligere videnskabelig læsning om 2. smittebølge, Delta-varianten, gennembrudsinfektioner, vaccineeffekt i efteråret/vinter 2021 samt Enforce-data på effekt ultimo 2021:
- Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
- SARS-CoV-2 variants and ending the COVID-19 pandemic
- Monoclonal antibody therapies against SARS-CoV-2
- Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Kapitel 20 – Omikron forandrer alt
- Risikovurdering af omikron
- Eksperter forstår intet: Indfør tiltag i kampen mod omikron, så færre mennesker ses
- 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021
- Seroprævalensundersøgelse af bloddonorer – 4. runde
- Dødeligheden på grund af covid-19 i Danmark stiger ikke svarende til smittetallene
- Where did Omicron come from? Three key theories
For yderligere videnskabelig læsning om Omikron og Enforce-data på Omikron:
- Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
- Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
- Evasion of neutralising antibodies by omicron sublineage BA.2.75
- Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
- Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study